Insider · CIK 0001982651
Melvina Wong-Zaza
Files at KRNY (Kearny Financial Corp.). First filing Nov 2, 2023, latest Sep 18, 2026.
In brief
Melvina Wong-Zaza files SEC Form 4 as director at KRNY (Kearny Financial Corp.). Since Nov 2, 2023, Melvina Wong-Zaza has reported 7 open-market buys worth $135k and 0 open-market sells worth $0, the latest filed on Sep 18, 2026.
After Melvina Wong-Zaza's past buys, the stock beat the S&P 500 by a median 4.0% over six months (n = 4), and 50% of those buys were ahead of the index at six months. InsiderTell labels that a positive record.
The newest scored trade: bought $15k of KRNY on Sep 17, 2026, filed Sep 18, 2026, scored 15 (weak). In the last 12 months: 2 buys worth $45k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KRNY: Kearny Financial Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | KRNYbuy Kearny Financial Corp. | $15k 1,560 shares | +5% | - | |
| 31Weak | Kearny Financial Corp. | $30k 3,500 shares | +12% | +58% from low0% from high | |
| 34Weak | KRNYbuy Kearny Financial Corp. | $8,154 1,375 shares | +5% | +6% from low-28% from high | |
| 32Weak | KRNYbuy Kearny Financial Corp. | $8,988 1,500 shares | +5% | +5% from low-29% from high | |
| 27Weak | KRNYbuy Kearny Financial Corp. | $36k 5,000 shares | +22% | - | |
| 66Notable | Kearny Financial Corp. | $26k 3,945 shares | +149% | +6% from low-32% from high | |
| 53Moderate | KRNYbuy Kearny Financial Corp. | $11k 1,600 shares | +152% | +7% from low-30% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | KRNY Kearny Financial Corp. | POpen-market purchase Common Stock | +1,560 | $9.64 | $15k | 35,470 | 26 d ago |
| Jun 11, 2026 | KRNY Kearny Financial Corp. | POpen-market purchase Common Stock | +3,500 | $8.58 | $30k | 33,910 | Jun 12, 2026 |
| Aug 8, 2025 | KRNY Kearny Financial Corp. | POpen-market purchase Common Stock | +1,375 | $5.93 | $8,154 | 30,410 | Aug 11, 2025 |
| Aug 1, 2025 | KRNY Kearny Financial Corp. | POpen-market purchase Common Stock | +1,500 | $5.99 | $8,988 | 29,035 | Aug 4, 2025 |
| Feb 7, 2025 | KRNY Kearny Financial Corp. | POpen-market purchase Common Stock | +5,000 | $7.23 | $36k | 27,535 | Feb 10, 2025 |
| Feb 14, 2024 | KRNY Kearny Financial Corp. | POpen-market purchase Common Stock | +3,245 | $6.48 | $21k | 5,895 | Feb 15, 2024 |
| Feb 14, 2024 | KRNY Kearny Financial Corp. | POpen-market purchase Common Stock | +700 | $6.41 | $4,487 | 6,595 | Feb 15, 2024 |
| Nov 1, 2023 | KRNY Kearny Financial Corp. | POpen-market purchase Common Stock | +1,600 | $6.97 | $11k | 2,650 | Nov 2, 2023 |
Questions about Melvina Wong-Zaza
Answered from the filings on this page, as of the latest one.
Is Melvina Wong-Zaza buying or selling?
In the last 12 months Melvina Wong-Zaza reported 2 open-market buys worth $45k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $15k of KRNY on Sep 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Melvina Wong-Zaza's past buys perform?
Measured from the first close after each filing, the stock beat the S&P 500 by a median 4.0% over six months across 4 past buys, with 50% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Melvina Wong-Zaza file Form 4?
Melvina Wong-Zaza has filed Form 4 at KRNY (Kearny Financial Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.